to accelerate the clinical development of drug candidate EYP001.
October 2, 2017

#drugR&D #insilicomedicine #systemsbiology #biomodeling #machinelearning
to accelerate the clinical development of drug candidate EYP001.
October 2, 2017
Watershed moment for in silico clinical trials as the FDA receives formal congressional requirement to apply in silico for the evaluation of new drugs.
In the presence of Mme Françoise Grossetête, Member of the European Parliament & Dr Adriano Henney, Secretary General of Avicenna Alliance.
The Avicenna Alliance has claimed a major victory in the revised EMA Regulation with the introduction of new text supporting modeling and simulation and predictive medicine in medicinal product development
The Avicenna Alliance, which Nova is a founding member of, releases its roadmap “in silico Clinical Trials: How Computer Simulation will Transform the Biomedical Industry”. This roadmap has been approved by the European Commission.
Novadiscovery secures an H2020 research grant for the RESSTORE project aimed at the clinical evaluation of a cell-based regenerative therapy in acute ischemic stroke
Novadiscovery is delighted to announce an award at the BIOVISION Catalyzer competition for its GitHealth open science platform.
A publication by Jean-Pierre Boissel, Charles Auffray, Denis Noble, Lee Hood, François-Henry Boissel in CPT Pharmacometrics Systems Pharmacololgy, March 2015 : Bridging systems medicine and patient needs
A personalized medicine project centered on breast, colorectal and lung cancers.
at the 20th-anniversary edition of the prestigious International Congress on Lung Transplantation, in Paris.